Geode Capital Management, LLC Puma Biotechnology, Inc. Transaction History

Geode Capital Management, LLC

  • $1.26 Trillion
  • Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 919,435 shares of PBYI stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
919,435
Previous 917,367 0.23%
Holding current value
$2.68 Million
Previous $2.34 Million 19.88%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$2.42 - $3.39 $5,004 - $7,010
2,068 Added 0.23%
919,435 $2.8 Million
Q3 2024

Nov 12, 2024
SELL
$2.25 - $4.03 $73,752 - $132,099
-32,779 Reduced 3.45%
917,367 $2.34 Million
Q2 2024

Aug 09, 2024
BUY
$2.92 - $5.83 $1.45 Million - $2.9 Million
497,175 Added 109.76%
950,146 $3.1 Million
Q1 2024

May 13, 2024
BUY
$4.29 - $7.4 $38,288 - $66,045
8,925 Added 2.01%
452,971 $2.4 Million
Q4 2023

Feb 13, 2024
BUY
$2.23 - $4.49 $41,324 - $83,204
18,531 Added 4.35%
444,046 $1.92 Million
Q3 2023

Nov 13, 2023
BUY
$2.63 - $4.09 $76,582 - $119,096
29,119 Added 7.35%
425,515 $1.12 Million
Q2 2023

Aug 11, 2023
BUY
$2.6 - $3.58 $12,412 - $17,090
4,774 Added 1.22%
396,396 $1.4 Million
Q1 2023

May 15, 2023
BUY
$2.21 - $4.82 $23,671 - $51,627
10,711 Added 2.81%
391,622 $1.21 Million
Q4 2022

Feb 13, 2023
BUY
$2.12 - $5.08 $13,239 - $31,724
6,245 Added 1.67%
380,911 $1.61 Million
Q3 2022

Nov 14, 2022
BUY
$2.27 - $3.84 $10,385 - $17,568
4,575 Added 1.24%
374,666 $887,000
Q2 2022

Aug 12, 2022
SELL
$1.64 - $3.3 $376,089 - $756,765
-229,323 Reduced 38.26%
370,091 $1.05 Million
Q1 2022

May 13, 2022
SELL
$2.13 - $3.24 $80,680 - $122,724
-37,878 Reduced 5.94%
599,414 $1.73 Million
Q4 2021

Feb 11, 2022
BUY
$2.85 - $6.58 $85,901 - $198,327
30,141 Added 4.96%
637,292 $1.94 Million
Q3 2021

Nov 12, 2021
SELL
$6.63 - $9.39 $92,654 - $131,225
-13,975 Reduced 2.25%
607,151 $4.26 Million
Q2 2021

Aug 13, 2021
BUY
$8.98 - $11.6 $168,267 - $217,360
18,738 Added 3.11%
621,126 $5.7 Million
Q1 2021

May 12, 2021
BUY
$9.38 - $13.63 $713,339 - $1.04 Million
76,049 Added 14.45%
602,388 $5.86 Million
Q4 2020

Feb 12, 2021
SELL
$7.78 - $12.13 $89,827 - $140,052
-11,546 Reduced 2.15%
526,339 $5.4 Million
Q3 2020

Nov 13, 2020
BUY
$9.5 - $11.14 $103,265 - $121,091
10,870 Added 2.06%
537,885 $5.43 Million
Q2 2020

Aug 13, 2020
BUY
$7.01 - $13.24 $382,591 - $722,612
54,578 Added 11.55%
527,015 $5.5 Million
Q1 2020

May 14, 2020
SELL
$6.28 - $14.57 $587,845 - $1.36 Million
-93,606 Reduced 16.54%
472,437 $3.99 Million
Q4 2019

Feb 13, 2020
BUY
$6.5 - $10.73 $1.06 Million - $1.75 Million
163,303 Added 40.55%
566,043 $4.95 Million
Q3 2019

Nov 12, 2019
BUY
$8.75 - $12.85 $71,120 - $104,444
8,128 Added 2.06%
402,740 $4.34 Million
Q2 2019

Aug 14, 2019
BUY
$12.3 - $35.76 $316,011 - $918,745
25,692 Added 6.96%
394,612 $5.02 Million
Q1 2019

May 14, 2019
BUY
$20.77 - $42.37 $686,469 - $1.4 Million
33,051 Added 9.84%
368,920 $14.3 Million
Q4 2018

Feb 13, 2019
BUY
$20.07 - $46.7 $237,628 - $552,928
11,840 Added 3.65%
335,869 $6.83 Million
Q3 2018

Nov 13, 2018
BUY
$41.2 - $59.85 $799,115 - $1.16 Million
19,396 Added 6.37%
324,029 $14.9 Million
Q2 2018

Aug 14, 2018
BUY
$48.3 - $68.25 $303,130 - $428,337
6,276 Added 2.1%
304,633 $18 Million
Q1 2018

May 15, 2018
BUY
$59.7 - $99.25 $457,660 - $760,850
7,666 Added 2.64%
298,357 $20.3 Million
Q4 2017

Feb 13, 2018
BUY
$93.85 - $132.45 $729,402 - $1.03 Million
7,772 Added 2.75%
290,691 $28.7 Million
Q3 2017

Nov 14, 2017
BUY
$72.0 - $119.75 $1.76 Million - $2.92 Million
24,379 Added 9.43%
282,919 $33.9 Million
Q2 2017

Aug 14, 2017
BUY
N/A
258,540
258,540 $22.6 Million

Others Institutions Holding PBYI

# of Institutions
110
Shares Held
28.3M
Call Options Held
27.9K
Put Options Held
3.4K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $133M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email